Compare AbCellera Biologics Inc (ABCL) vs Upstart Holdings Inc (UPST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Upstart Holdings Inc — how do they compare? AbCellera Biologics Inc trades at $8.93 (market cap $2.85B), while Upstart Holdings Inc trades at $29.98 (market cap $2.94B). The key difference: AbCellera Biologics Inc and Upstart Holdings Inc are close in size by market cap, and AbCellera Biologics Inc is trading nearer its 52-week high, Upstart Holdings Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | UPST | |
|---|---|---|
Market Cap | $2.85B | $2.94B |
Sector | Health | Financials |
52-Week High | $9.76 | $73.76 |
52-Week Low | $2.78 | $24.22 |
Enterprise Value | $2.45B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Upstart Holdings Inc
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. The revenue of the company is primarily comprised of fees paid by banks.
Read more on UPST →
